Life Science REIT has agreed a lease extension with Carl Zeiss at Cambourne Park Science & Technology Campus.
The global technology and life science company, which occupies 43,300 sq ft in Building 1030, has extended its lease by five years from 2028 to 2033. The rent will remain unchanged, but it is subject to review in 2028.
As part of the agreement, Carl Zeiss, which is the park’s biggest tenant, will undertake a programme of works which will include replacing the existing gas boilers and installing photovoltaic panels.
Ian Harris, director of asset management at Ironstone Asset Management, Life Science REIT’s investment adviser, said: “As a pioneer in the life sciences industry and the largest single occupier at Cambourne, Carl Zeiss’s recommitment to the park demonstrates its appeal as a successful and well-established life sciences destination.
“We are highly supportive of the work Carl Zeiss is undertaking to improve the environmental credentials of its space, which are in line with the repurposing initiatives being delivered elsewhere on the park, and which progress Life Science REIT’s pathway to net zero.”
